HYPR
Hyperfine, Inc.
Key Financials
Operating Income
$-37085000
↑ 14.2%
Net Income
$-35574000
↑ 12.6%
Gross Profit
$6.8M
↑ 14.6%
EPS (Diluted)
$-0.43
↑ 23.2%
Total Assets
$55.3M
↓ 6.2%
Total Liabilities
$14.3M
↑ 44.6%
Revenue
$13.6M
↑ 5.2%
Long-term Debt
$13.2M
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/18/2026 | View on SEC |
| 4 | 8/25/2026 | View on SEC |
| 4 | 8/25/2026 | View on SEC |
| 10-Q | 8/6/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| SCHEDULE 13G | 7/28/2026 | View on SEC |
| 4 | 6/4/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 4 | 5/22/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HYPR |
| Company Name | Hyperfine, Inc. |
| CIK | 1833769 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 866-796-6767 |